Dysregulation of toll-like receptor 7 compromises innate and adaptive T cell responses and host resistance to an attenuated West Nile virus infection in old mice

Journal of Virology

Volumn 90, Issue 3, 2016, Pages 1333-1344

  Xie, Guorui ^a   Luo, Huanle ^a   Pang, Lan ^a   Peng, Bi hung ^a   Winkelmann, Evandro ^a   McGruder, Brenna ^a   Hesse, Joseph ^a   Whiteman, Melissa ^a   Campbell, Gerald ^a   Milligan, Gregg N ^a   Cong, Yingzi ^a   Barrett, Alan D ^a   Wang, Tian ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; CYTOKINE; INTERLEUKIN 10; RESIQUIMOD; TOLL LIKE RECEPTOR 7;

ADAPTIVE IMMUNITY; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; EX VIVO STUDY; FLAVIVIRUS INFECTION; GAMMA DELTA T LYMPHOCYTE; IMMUNIZATION; INFECTION CONTROL; INFECTION SENSITIVITY; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; VIRUS CELL INTERACTION; WEST NILE VIRUS; ANIMAL; C57BL MOUSE; CYTOCHEMISTRY; DISEASE RESISTANCE; IMMUNOLOGY; METABOLISM; PATHOLOGY; SURVIVAL ANALYSIS; T LYMPHOCYTE; VIRUS LOAD; WEST NILE FEVER;

ADAPTIVE IMMUNITY; AGE FACTORS; ANIMALS; DISEASE RESISTANCE; HISTOCYTOCHEMISTRY; IMMUNITY, INNATE; MICE, INBRED C57BL; SURVIVAL ANALYSIS; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 7; VIRAL LOAD; WEST NILE FEVER; WEST NILE VIRUS;

EID: 84958093696     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02488-15     Document Type: Article

References (73)

1. Campbell GL, Marfin AA, Lanciotti RS, Gubler DJ. 2002. West Nile virus. Lancet Infect Dis 2:519-529. http://dx.doi.org/10.1016/S1473-3099(02)00368-7.
2. Solomon T, Ooi MH, Beasley DW, Mallewa M. 2003. West Nile encephalitis. BMJ 326:865-869. http://dx.doi.org/10.1136/bmj.326.7394.865.
3. Wang T, Fikrig E. 2004. Immunity to West Nile virus. Curr Opin Immunol 16:519-523. http://dx.doi.org/10.1016/j.coi.2004.05.008.
4. Anderson JF, Andreadis TG, Vossbrinck CR, Tirrell S, Wakem EM, French RA, Garmendia AE, Van Kruiningen HJ. 1999. Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut. Science 286:2331-2333. http://dx.doi.org/10.1126/science.286.5448.2331.
5. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker M, Steele K, Crise B, Volpe KE, Crabtree MB, Scherret JH, Hall RA, MacKenzie JS, Cropp CB, Panigrahy B, Ostlund E, Schmitt B, Malkinson M, Banet C, Weissman J, Komar N, Savage HM, Stone W, McNamara T, Gubler DJ. 1999. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 286:2333-2337. http://dx.doi.org/10.1126/science.286.5448.2333.
6. Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, Lipkin WI, Garcia-Sastre A. 2005. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79:8004-8013. http://dx.doi.org/10.1128/JVI.79.13.8004-8013.2005.
7. Liu WJ, Wang XJ, Mokhonov VV, Shi PY, Randall R, Khromykh AA. 2005. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol 79:1934-1942. http://dx.doi.org/10.1128/JVI.79.3.1934-1942.2005.
8. Evans JD, Seeger C. 2007. Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling. J Virol 81:11809-11816. http://dx.doi.org/10.1128/JVI.00791-07.
9. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A. 2003. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 100:14333-14338. http://dx.doi.org/10.1073/pnas.2335168100.
10. Wicker JA, Whiteman MC, Beasley DW, Davis CT, McGee CE, Lee JC, Higgs S, Kinney RM, Huang CY, Barrett AD. 2012. Mutational analysis of the West Nile virus NS4B protein. Virology 426:22-33. http://dx.doi.org/10.1016/j.virol.2011.11.022.
11. Welte T, Xie G, Wicker JA, Whiteman MC, Li L, Rachamallu A, Barrett A, Wang T. 2011. Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain. Vaccine 29:4853-4861. http://dx.doi.org/10.1016/j.vaccine.2011.04.057.
12. Xie G, Luo H, Tian B, Mann B, Bao X, McBride J, Tesh R, Barrett AD, Wang T. 2015. A West Nile virus NS4B-P38G mutant strain induces cell intrinsic innate cytokine responses in human monocytic and macrophage cells. Vaccine 33:869-878. http://dx.doi.org/10.1016/j.vaccine.2014.12.056.
13. Brien JD, Uhrlaub JL, Hirsch A, Wiley CA, Nikolich-Zugich J. 2009. Key role of T cell defects in age-related vulnerability to West Nile virus. J Exp Med 206:2735-2745. http://dx.doi.org/10.1084/jem.20090222.
14. Welte T, Lamb J, Anderson JF, Born WK, O'Brien RL, Wang T. 2008. Role of two distinct gammadelta T cell subsets during West Nile virus infection. FEMS Immunol Med Microbiol 53:275-283. http://dx.doi.org/10.1111/j.1574-695X.2008.00430.x.
15. Town T, Bai F, Wang T, Kaplan AT, Qian F, Montgomery RR, Anderson JF, Flavell RA, Fikrig E. 2009. Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing. Immunity 30:242-253. http://dx.doi.org/10.1016/j.immuni.2008.11.012.
16. Welte T, Reagan K, Fang H, Machain-Williams C, Zheng X, Mendell N, Chang GJ, Wu P, Blair CD, Wang T. 2009. Toll-like receptor 7-induced immune response to cutaneous West Nile virus infection. J Gen Virol 90:2660-2668. http://dx.doi.org/10.1099/vir.0.011783-0.
17. Xie G, Welte T, Wang J, Whiteman MC, Wicker JA, Saxena V, Cong Y, Barrett AD, Wang T. 2013. A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathways. Vaccine 31:4143-4151. http://dx.doi.org/10.1016/j.vaccine.2013.06.093.
18. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3:196-200. http://dx.doi.org/10.1038/ni758.
19. Daffis S, Samuel MA, Suthar MS, Keller BC, Gale M, Jr, Diamond MS. 2008. Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol 82:8465-8475. http://dx.doi.org/10.1128/JVI.00918-08.
20. Lanciotti RS, Kerst AJ, Nasci RS, Godsey MS, Mitchell CJ, Savage HM, Komar N, Panella NA, Allen BC, Volpe KE, Davis BS, Roehrig JT. 2000. Rapid detection of West Nile virus from human clinical specimens, fieldcollected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol 38:4066-4071.
21. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10:1366-1373. http://dx.doi.org/10.1038/nm1140.
22. Edwards AD, Diebold SS, Slack EM, Tomizawa H, Hemmi H, Kaisho T, Akira S, Reis e Sousa C. 2003. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha + DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 33:827-833. http://dx.doi.org/10.1002/eji.200323797.
23. Welte T, Aronson J, Gong B, Rachamallu A, Mendell N, Tesh R, Paessler S, Born WK, O'Brien RL, Wang T. 2011. Vgamma4+ T cells regulate host immune response to West Nile virus infection. FEMS Immunol Med Microbiol 63:183-192. http://dx.doi.org/10.1111/j.1574-695X.2011.00840.x.
24. Wang S, Welte T, McGargill M, Town T, Thompson J, Anderson JF, Flavell RA, Fikrig E, Hedrick SM, Wang T. 2008. Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis. J Immunol 181:2084-2091. http://dx.doi.org/10.4049/jimmunol.181.3.2084.
25. Brien JD, Uhrlaub JL, Nikolich-Zugich J. 2008. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J Immunol 181:8568-8575. http://dx.doi.org/10.4049/jimmunol.181.12.8568.
26. Brien JD, Uhrlaub JL, Nikolich-Zugich J. 2007. Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection. Eur J Immunol 37:1855-1863. http://dx.doi.org/10.1002/eji.200737196.
27. Purtha WE, Myers N, Mitaksov V, Sitati E, Connolly J, Fremont DH, Hansen TH, Diamond MS. 2007. Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis. Eur J Immunol 37:1845-1854. http://dx.doi.org/10.1002/eji.200737192.
28. Samuel MA, Diamond MS. 2005. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J Virol 79:13350-13361. http://dx.doi.org/10.1128/JVI.79.21.13350-13361.2005.
29. Bai F, Town T, Qian F, Wang P, Kamanaka M, Connolly TM, Gate D, Montgomery RR, Flavell RA, Fikrig E. 2009. IL-10 signaling blockade controls murine West Nile virus infection. PLoS Pathog 5:e1000610. http://dx.doi.org/10.1371/journal.ppat.1000610.
30. Schneider BS, McGee CE, Jordan JM, Stevenson HL, Soong L, Higgs S. 2007. Prior exposure to uninfected mosquitoes enhances mortality in naturally-transmitted West Nile virus infection. PLoS One 2:e1171. http://dx.doi.org/10.1371/journal.pone.0001171.
31. Wang T, Scully E, Yin Z, Kim JH, Wang S, Yan J, Mamula M, Anderson JF, Craft J, Fikrig E. 2003. IFN-gamma-producing gammadelta T cells help control murine West Nile virus infection. J Immunol 171:2524-2531. http://dx.doi.org/10.4049/jimmunol.171.5.2524.
32. Roehrig JT, Staudinger LA, Hunt AR, Mathews JH, Blair CD. 2001. Antibody prophylaxis and therapy for flavivirus encephalitis infections. Ann N Y Acad Sci 951:286-297.
33. Diamond MS, Shrestha B, Marri A, Mahan D, Engle M. 2003. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J Virol 77:2578-2586. http://dx.doi.org/10.1128/JVI.77.4.2578-2586.2003.
34. Shrestha B, Samuel MA, Diamond MS. 2006. CD8+ T cells require perforin to clear West Nile virus from infected neurons. J Virol 80:119-129. http://dx.doi.org/10.1128/JVI.80.1.119-129.2006.
35. Wang Y, Lobigs M, Lee E, Mullbacher A. 2003. CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol 77:13323-13334. http://dx.doi.org/10.1128/JVI.77.24.13323-13334.2003.
36. Qian F, Wang X, Zhang L, Lin A, Zhao H, Fikrig E, Montgomery RR. 2011. Impaired interferon signaling in dendritic cells from older donors infected in vitro with West Nile virus. J Infect Dis 203:1415-1424. http://dx.doi.org/10.1093/infdis/jir048.
37. Fredericksen BL, Gale M, Jr. 2006. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and-independent pathways without antagonizing host defense signaling. J Virol 80: 2913-2923. http://dx.doi.org/10.1128/JVI.80.6.2913-2923.2006.
38. Daffis S, Samuel MA, Suthar MS, Gale M, Jr, Diamond MS. 2008. Toll-like receptor 3 has a protective role against West Nile virus infection. J Virol 82:10349-10358. http://dx.doi.org/10.1128/JVI.00935-08.
39. Zhang J, Wang J, Pang L, Xie G, Welte T, Saxena V, Wicker J, Mann B, Soong L, Barrett A, Born W, O'Brien R, Wang T. 2014. The costimulatory effects of MyD88-dependent Toll-like receptor signaling on activation of murine gammadelta T cells. PLoS One 9:e108156. http://dx.doi.org/10.1371/journal.pone.0108156.
40. Garg SK, Delaney C, Toubai T, Ghosh A, Reddy P, Banerjee R, Yung R. 2014. Aging is associated with increased regulatory T-cell function. Aging Cell 13:441-448. http://dx.doi.org/10.1111/acel.12191.
41. Verschoor CP, Johnstone J, Millar J, Dorrington MG, Habibagahi M, Lelic A, Loeb M, Bramson JL, Bowdish DM. 2013. Blood CD33(+)HLADR(+) myeloid-derived suppressor cells are increased with age and a history of cancer. J Leukoc Biol 93:633-637. http://dx.doi.org/10.1189/jlb.0912461.
42. Jeisy-Scott V, Kim JH, Davis WG, Cao W, Katz JM, Sambhara S. 2012. TLR7 recognition is dispensable for influenza virus A infection, but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice. J Virol 86:10988-10998. http://dx.doi.org/10.1128/JVI.01064-12.
43. Beasley DW. 2011. Safety and immunogenicity of a chimeric vaccine for West Nile virus in aged subjects. Expert Rev Vaccines 10:601-604. http://dx.doi.org/10.1586/erv.11.47.
44. Uhrlaub JL, Brien JD, Widman DG, Mason PW, Nikolich-Zugich J. 2011. Repeated in vivo stimulation of T and B cell responses in old mice generates protective immunity against lethal West Nile virus encephalitis. J Immunol 186:3882-3891. http://dx.doi.org/10.4049/jimmunol.1002799.
45. Panda A, Qian F, Mohanty S, van Duin D, Newman FK, Zhang L, Chen S, Towle V, Belshe RB, Fikrig E, Allore HG, Montgomery RR, Shaw AC. 2010. Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol 184:2518-2527. http://dx.doi.org/10.4049/jimmunol.0901022.
46. Shaw AC, Panda A, Joshi SR, Qian F, Allore HG, Montgomery RR. 2011. Dysregulation of human Toll-like receptor function in aging. Ageing Res Rev 10:346-353. http://dx.doi.org/10.1016/j.arr.2010.10.007.
47. Wang T, Welte T, Saxena V, Xie G. 2011. Immunity versus immunopathology in West Nile virus induced encephalitis. In Ruzek D (ed), Flavivirus encephalitis InTech. http://dx.doi.org/10.5772/20355.
48. Wesch D, Beetz S, Oberg HH, Marget M, Krengel K, Kabelitz D. 2006. Direct costimulatory effect of TLR3 ligand poly(I:C) on human gamma delta T lymphocytes. J Immunol 176:1348-1354. http://dx.doi.org/10.4049/jimmunol.176.3.1348.
49. Xie G, Whiteman MC, Wicker JA, Barrett AD, Wang T. 2014. In vitro analysis of MyD88-mediated cellular immune response to West Nile virus mutant strain infection. J Vis Exp http://dx.doi.org/10.3791/52121:e52121.
50. Fang H, Welte T, Zheng X, Chang GJ, Holbrook MR, Soong L, Wang T. 2010. Gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection. FEMS Immunol Med Microbiol 59:71-80. http://dx.doi.org/10.1111/j.1574-695X.2010.00663.x.
51. Jones SC, Brahmakshatriya V, Huston G, Dibble J, Swain SL. 2010. TLR-activated dendritic cells enhance the response of aged naive CD4 T cells via an IL-6-dependent mechanism. J Immunol 185:6783-6794. http://dx.doi.org/10.4049/jimmunol.0901296.
52. Lanteri MC, O'Brien KM, Purtha WE, Cameron MJ, Lund JM, Owen RE, Heitman JW, Custer B, Hirschkorn DF, Tobler LH, Kiely N, Prince HE, Ndhlovu LC, Nixon DF, Kamel HT, Kelvin DJ, Busch MP, Rudensky AY, Diamond MS, Norris PJ. 2009. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J Clin Invest 119:3266-3277. http://dx.doi.org/10.1172/JCI39387.
53. Williams-Bey Y, Jiang J, Murasko DM. 2011. Expansion of regulatory T cells in aged mice following influenza infection. Mech Ageing Dev 132: 163-170. http://dx.doi.org/10.1016/j.mad.2011.03.001.
54. Lalive PH, Benkhoucha M, Tran NL, Kreutzfeldt M, Merkler D, Santiago-Raber ML. 2014. TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3+Treg cells. Eur J Immunol 44:46-57. http://dx.doi.org/10.1002/eji.201242985.
55. Hackl D, Loschko J, Sparwasser T, Reindl W, Krug AB. 2011. Activation of dendritic cells via TLR7 reduces Foxp3 expression and suppressive function in induced Tregs. Eur J Immunol 41:1334-1343. http://dx.doi.org/10.1002/eji.201041014.
56. Van LP, Bardel E, Gregoire S, Vanoirbeek J, Schneider E, Dy M, Thieblemont N. 2011. Treatment with the TLR7 agonist R848 induces regulatory T-cell-mediated suppression of established asthma symptoms. Eur J Immunol 41:1992-1999. http://dx.doi.org/10.1002/eji.201040914.
57. Forward NA, Furlong SJ, Yang Y, Lin TJ, Hoskin DW. 2010. Signaling through TLR7 enhances the immunosuppressive activity of murine CD4+CD25+ T regulatory cells. J Leukoc Biol 87:117-125. http://dx.doi.org/10.1189/jlb.0908559.
58. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J. 2003. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197:403-411. http://dx.doi.org/10.1084/jem.20021633.
59. Kong KF, Delroux K, Wang X, Qian F, Arjona A, Malawista SE, Fikrig E, Montgomery RR. 2008. Dysregulation of TLR3 impairs the innate immune response to West Nile virus in the elderly. J Virol 82:7613-7623. http://dx.doi.org/10.1128/JVI.00618-08.
60. Jeisy-Scott V, Davis WG, Patel JR, Bowzard JB, Shieh WJ, Zaki SR, Katz JM, Sambhara S. 2011. Increased MDSC accumulation and Th2 biased response to influenza A virus infection in the absence of TLR7 in mice. PLoS One 6:e25242. http://dx.doi.org/10.1371/journal.pone.0025242.
61. Pham NL, Badovinac VP, Harty JT. 2009. A default pathway of memory CD8 T cell differentiation after dendritic cell immunization is deflected by encounter with inflammatory cytokines during antigendriven proliferation. J Immunol 183:2337-2348. http://dx.doi.org/10.4049/jimmunol.0901203.
62. Chandran SS, Verhoeven D, Teijaro JR, Fenton MJ, Farber DL. 2009. TLR2 engagement on dendritic cells promotes high frequency effector and memory CD4 T cell responses. J Immunol 183:7832-7841. http://dx.doi.org/10.4049/jimmunol.0901683.
63. Conti L, Casetti R, Cardone M, Varano B, Martino A, Belardelli F, Poccia F, Gessani S. 2005. Reciprocal activating interaction between dendritic cells and pamidronate-stimulated gammadelta T cells: role of CD86 and inflammatory cytokines. J Immunol 174:252-260. http://dx.doi.org/10.4049/jimmunol.174.1.252.
64. Dieli F, Caccamo N, Meraviglia S, Ivanyi J, Sireci G, Bonanno CT, Ferlazzo V, La Mendola C, Salerno A. 2004. Reciprocal stimulation of gammadelta T cells and dendritic cells during the anti-mycobacterial immune response. Eur J Immunol 34:3227-3235. http://dx.doi.org/10.1002/eji.200425368.
65. Badovinac VP, Tvinnereim AR, Harty JT. 2000. Regulation of antigenspecific CD8+T cell homeostasis by perforin and interferon-gamma. Science 290:1354-1358. http://dx.doi.org/10.1126/science.290.5495.1354.
66. Curtsinger JM, Valenzuela JO, Agarwal P, Lins D, Mescher MF. 2005. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J Immunol 174:4465-4469. http://dx.doi.org/10.4049/jimmunol.174.8.4465.
67. Xiao Z, Casey KA, Jameson SC, Curtsinger JM, Mescher MF. 2009. Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol 182:2786-2794. http://dx.doi.org/10.4049/jimmunol.0803484.
68. Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, Hammerbeck CD, Popescu F, Xiao Z. 2006. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 211:81-92. http://dx.doi.org/10.1111/j.0105-2896.2006.00382.x.
69. Zimmermann S, Dalpke A, Heeg K. 2008. CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections. Int J Med Microbiol 298:39-44. http://dx.doi.org/10.1016/j.ijmm.2007.07.011.
70. Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, Schoen RT, Medzhitov R, Fikrig E, Flavell RA. 2002. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1-and TLR2-deficient mice. Nat Med 8:878-884.
71. Lahiri A, Das P, Chakravortty D. 2008. Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond. Vaccine 26:6777-6783. http://dx.doi.org/10.1016/j.vaccine.2008.09.045.
72. Kastenmuller K, Wille-Reece U, Lindsay RW, Trager LR, Darrah PA, Flynn BJ, Becker MR, Udey MC, Clausen BE, Igyarto BZ, Kaplan DH, Kastenmuller W, Germain RN, Seder RA. 2011. Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets. J Clin Invest 121:1782-1796. http://dx.doi.org/10.1172/JCI45416.
73. Vasilakos JP, Tomai MA. 2013. The use of Toll-like receptor 7/8 agonists as vaccine adjuvants. Expert Rev Vaccines 12:809-819. http://dx.doi.org/10.1586/14760584.2013.811208.